Abstract
Background GrimAge acceleration (GrimAgeAccel) and PhenoAge acceleration (PhenoAgeAccel) are DNA methylation-based markers of accelerated biological ageing, standing out in predicting mortality and age-related cardiometabolic morbidities. Causal risk factors for GrimAgeAccel and PhenoAgeAccel are unclear.
Objective To evaluate causal associations of 18 common modifiable socioeconomic, lifestyle, and cardiometabolic factors with GrimAgeAccel and PhenoAgeAccel.
Methods We performed two-sample univariable and multivariable Mendelian randomization (MR), using summary-level data for GrimAgeAccel and PhenoAgeAccel derived from a genome-wide association study of 34,710 European participants. We used the inverse-variance weighted method as the main analysis, supplemented by three sensitivity analyses.
Results Eleven and eight factors were causally associated with GrimAgeAccel and PhenoAgeAccel, respectively. Smoking initiation was the strongest risk factor (β [SE]: 1.299 [0.107] years) for GrimAgeAccel, followed by higher alcohol intake, higher waist circumference, daytime napping, higher body fat percentage, higher BMI, higher C-reactive protein, higher triglycerides, childhood obesity, and type 2 diabetes; whereas education was the strongest protective factor (β [SE] per 1-SD increase in years of schooling: -1.143 [0.121] years). Higher waist circumference (β [SE]: 0.850 [0.269] years) and education (β [SE]: -0.718 [0.151] years) were the leading causal risk and protective factors for PhenoAgeAccel, respectively. Sensitivity analyses strengthened the robustness of these causal associations, and the multivariable MR analyses demonstrated independent direct effects of the strongest risk and protective factors on GrimAgeAccel and PhenoAgeAccel, respectively.
Conclusion Our findings provide novel quantitative evidence on modifiable causal risk factors for epigenetic ageing, and hint at underlying contributors and intervention targets to the ageing process.
Key Points
Genetically predicted higher educational attainment is the strongest protective factor for both GrimAgeAccel and PhenoAgeAccel, independent of causal lifestyle and cardiometabolic risk factors.
Smoking is the leading causal lifestyle risk factor for GrimAgeAccel or PhenoAgeAccel, followed by alcohol intake and daytime napping. Adiposity traits are the leading causal cardiometabolic risk factors for GrimAgeAccel and PhenoAgeAccel, followed by type 2 diabetes, triglycerides, and C-reactive protein.
This study provides novel quantitative evidence on modifiable causal risk factors for accelerated epigenetic ageing, indicating underlying contributors to the ageing process and promising intervention targets to promote healthy longevity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the grants from the National Natural Science Foundation of China (82022011, 81970706, 81730023, 82088102, 81970728, 81941017), the Chinese Academy of Medical Sciences (2018PT32017, 2019PT330006), the Shanghai Municipal Education Commission Gaofeng Clinical Medicine Grant Support from Shanghai Jiao Tong University School of Medicine (20171901 Round 2), the Shanghai Shenkang Hospital Development Center (SHDC12019101, SHDC2020CR1001A, SHDC2020CR3064B), the Shanghai Jiao Tong University School of Medicine (DLY201801), and the Ruijin Hospital (2018CR002).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study is based on publicly available data. The genetic association data of the 18 modifiable factors are available in Table 1. The GWAS summary statistics for GrimAgeAccel and PhenoAgeAccel are available at https://datashare.is.ed.ac.uk/handle/10283/3645.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Figure 2 and Figure 3 revised;Supplemental files updated.
Data Availability
This study is based on publicly available data. The genetic association data of the 18 modifiable factors are available in Table 1. The GWAS summary statistics for GrimAgeAccel and PhenoAgeAccel are available at https://datashare.is.ed.ac.uk/handle/10283/3645.
List of abbreviations
- BF%
- Body fat percentage
- BMI
- Body mass index
- CI
- Confidence interval
- CpG
- Cytosine-phosphate-guanine
- CRP
- C-reactive protein
- DBP
- Diastolic blood pressure
- FDR
- False discovery rate
- GrimAgeAccel
- GrimAge acceleration
- GWAS
- Genome-wide association study
- HDL
- High-density lipoprotein
- IV
- Instrumental variable
- IVW
- Inverse variance weighted
- LDL
- Low-density lipoprotein
- MVPA
- Moderate-to vigorous physical activity
- MR
- Mendelian randomization
- MVMR
- Multivariable Mendelian randomization
- PhenoAgeAccel
- PhenoAge acceleration
- PRESSO
- Pleiotropy residual sum and outlier
- SBP
- Systolic blood pressure
- SD
- Standard deviation
- SE
- Standard errors
- SNP
- Single nucleotide polymorphism
- WM
- Weighted median
